Syphilis Vaccine Development
Dr. Caroline Cameron and Dr. Lorenzo Giovani | November 16, 2022 12-1pm ET
Learning objectives: (1) Introduce the need for a syphilis vaccine. (2) Explore the concept of vaccine development to combat local and disseminated syphilis infection to prevent disease spread and symptoms, respectively. (3) Provide up-to-date progress on development of a subunit syphilis vaccine.
***This webinar was not recorded.***
ABOUT THE SPEAKER: Dr. Caroline Cameron
Professor, University of Victoria
Dr. Caroline Cameron is a Professor in the Department of Biochemistry and Microbiology at the University of Victoria and an Affiliate Professor in the Department of Medicine, Division of Allergy and Infectious Diseases at the University of Washington in Seattle, Washington, USA. She served as President of the International Society for Sexually Transmitted Diseases Research from 2017-2019, and her research has been recognized by the award of a Tier 2 Canada Research Chair and an NIH MERIT Award. Her lab focuses on studying pathogenic mechanisms of the bacterium that causes syphilis, Treponema pallidum.
ABOUT THE SPEAKER: Dr. Lorenzo Giovani
Associate Professor, University of Washington
Dr. Lorenzo Giacani is currently an Associate Professor in the Department of Medicine, Division of Allergy and infectious Diseases, and an Adjunct faculty member in the Department of Global Health at the university of Washington. He is also a CDC part-time employee in the syphilis team. His research interests revolve around studying syphilis pathogenesis and evaluating new therapies and vaccine candidates for syphilis. Throughout his career, he has received the ASTDA Developmental Award. He is the first investigator ever to have developed a technique to genetically engineer the syphilis agent.
ABOUT THE MODERATOR: Dr. Marc Steben
Dr. Steben is a Family physician, President of IUSTI Canada and President-elect of the International Society for STD Research. As a family physician, Marc concentrates his clinical interest on sexual health, mainly chronic genital diseases. Research, development and publications field include therapeutic approaches to chronic genital pain, prevention and treatment of genital herpes and development of HPV prophylactic vaccine.
